Search

Reset

Searching with a thematic focus on Intellectual Property Rights, Trade Policy

Showing 1-10 of 420 results

Pages

  • Document

    How effective has the Generics Act Been?

    Philippine Institute for Development Studies, 2016
    The Philippine government passed the Generics Act of 1988 to ensure that inexpensive and effective drugs are made available to all Filipinos. The law aims to supply and promote low-priced quality medicines as alternatives to the widely consumed but more expensive originator brands by requiring physicians to include in their prescriptions both the generic and brand names of the medicines.
  • Document

    Intellectual property rights: talking points for RP-US FTA negotiations

    Philippine Institute for Development Studies, 2006
    This paper discusses certain issues and questions on adequacy of intellectual property laws, enforcement and protection of intellectual property rights and improved market access for persons and entities relying on intellectual property rights, in the light of the proposed negotiations for an RP (Philippines) - US Free Trade Agreement.
  • Document

    India Africa partnership in healthcare: accomplishments and propsects

    Research and Information System for Developing Countries, 2015
    In the decades following India’s independence, the principle of South-South cooperation, particularly in the context of the non-aligned movement, has been at the forefront of India’s foreign policy towards Africa. Now, India and Africa are prepared more than ever to re-establish economic and political relationships to promote their mutual interests.
  • Document

    Access, Technology development and national IPR policy

    Research and Information System for Developing Countries, 2015
    The Government of India is engaged in drafting a new National IPR (Intellectual Property Right) Policy. This is the first time that the Government has undertaken such a task. So far there has been no formal policy statement encompassing all the Intellectual Property Rights, mentioned in the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement).
  • Document

    Emerging seed markets: the role of Brazilian, Chinese and Indian seeds in African agriculture

    Future Agricultures Consortium, 2014
    In recent years, three of the largest emerging powers, Brazil, China and India, have all brought about incredible agricultural revolutions and seeds have played a big part in that story. Nowadays, their seed markets are all within the world’s top ten in terms of value and their companies are eager to expand into new markets, particularly in Africa.
  • Document

    Developing new technologies to address neglected diseases: the role of Product Development Partnerships and Advanced Market Commitments - Developing-new-technologies-to-address-neglected-diseases.pdf

    DFID Health Resource Centre (HRC), 2006
    This paper focuses on the complementary roles of Product Development Partnerships (PDPs) and Advanced Market Commitments (AMCs), as mechanisms to incentivise industry towards the development of health technologies for neglected diseases.
  • Document

    India’s growing dependence on imports in the area of bulk drugs

    Research and Information System for Developing Countries, 2015
    In the background of concerns being voiced by pharmaceutical industry and academics as well as policymakers, RIS organised a Colloquium on India’s Growing Dependence on Imports in the Area of Bulk Drugs in New Delhi on 23 December 2014 to provide inputs for government policymaking. The Colloquium observed that:
  • Document

    IP Rights, Innovation and Development Priorities: Need for Balance

    Research and Information System for Developing Countries, 2015
    The Government of India is in the process of rolling out a National IPR Policy to signal an Intellectual Property (IP) friendly domestic business environment to the international audience.
  • Document

    Drug discovery and development: business opportunities in India

    Observer Research Foundation, New Delhi, 2009
    The sustainability of traditional pharmaceutical Research & Development model is being questioned with changing market dynamics, emerging markets and saturating growth rates in developed markets. New technological innovations in Research & Development in the past have been the source of competitive advantage.
  • Document

    Dynamics of pharmaceutical quality systems for the export of pharmaceuticals from India to Africa

    Knowledge Partnership Programme, 2014
    With its pharmaceutical exports, India has been contributing to public health globally and is often referred to as the ‘pharmaceutical factory’ to the world. For example, India has a dominant global market share of anti-retrovirals (80%) and paediatric ARVs (90%) in the world.

Pages